TNFSF9
Basic information
Region (hg38): 19:6531026-6535924
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TNFSF9 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 17 | 20 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 17 | 2 | 1 |
Variants in TNFSF9
This is a list of pathogenic ClinVar variants found in the TNFSF9 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
19-6531046-G-A | not specified | Uncertain significance (Sep 25, 2023) | ||
19-6531052-G-A | not specified | Uncertain significance (Dec 21, 2022) | ||
19-6531062-T-C | not specified | Uncertain significance (Oct 17, 2024) | ||
19-6531112-G-C | not specified | Likely benign (Mar 16, 2022) | ||
19-6531116-T-A | not specified | Uncertain significance (Jan 18, 2025) | ||
19-6531160-G-A | Benign (Feb 01, 2023) | |||
19-6531160-G-C | not specified | Uncertain significance (Mar 15, 2024) | ||
19-6531190-C-T | not specified | Uncertain significance (Mar 31, 2023) | ||
19-6531205-G-C | not specified | Uncertain significance (Nov 14, 2024) | ||
19-6531230-C-G | not specified | Uncertain significance (Dec 20, 2023) | ||
19-6534632-A-G | not specified | Uncertain significance (Oct 05, 2021) | ||
19-6534663-C-T | not specified | Uncertain significance (Jan 07, 2022) | ||
19-6534711-A-G | not specified | Uncertain significance (Nov 10, 2024) | ||
19-6534717-G-C | Likely benign (Aug 28, 2018) | |||
19-6534720-T-G | Uncertain significance (Apr 12, 2024) | |||
19-6534845-A-G | not specified | Uncertain significance (Jul 17, 2024) | ||
19-6534905-C-G | not specified | Uncertain significance (Sep 25, 2023) | ||
19-6534926-G-A | not specified | Uncertain significance (Dec 26, 2023) | ||
19-6534952-C-A | not specified | Uncertain significance (Mar 03, 2025) | ||
19-6534953-A-C | not specified | Uncertain significance (Mar 03, 2025) | ||
19-6534965-G-A | not specified | Uncertain significance (Jul 14, 2024) | ||
19-6534974-G-A | not specified | Uncertain significance (May 31, 2023) | ||
19-6534987-C-T | not specified | Uncertain significance (Jun 26, 2024) | ||
19-6534993-G-A | not specified | Uncertain significance (Jan 29, 2024) | ||
19-6535052-C-G | not specified | Uncertain significance (Feb 13, 2025) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
TNFSF9 | protein_coding | protein_coding | ENST00000245817 | 3 | 4922 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.318 | 0.620 | 125638 | 0 | 1 | 125639 | 0.00000398 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.480 | 169 | 152 | 1.11 | 0.00000892 | 1527 |
Missense in Polyphen | 33 | 35.96 | 0.91769 | 359 | ||
Synonymous | 0.130 | 79 | 80.5 | 0.982 | 0.00000497 | 619 |
Loss of Function | 1.44 | 1 | 4.18 | 0.239 | 1.80e-7 | 43 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00000880 | 0.00000880 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Cytokine that binds to TNFRSF9. Induces the proliferation of activated peripheral blood T-cells. May have a role in activation-induced cell death (AICD). May play a role in cognate interactions between T-cells and B-cells/macrophages. {ECO:0000269|PubMed:20032458}.;
- Pathway
- Cytokine-cytokine receptor interaction - Homo sapiens (human);miR-targeted genes in leukocytes - TarBase;miR-targeted genes in lymphocytes - TarBase;Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling;the 41bb-dependent immune response;TNFR2 non-canonical NF-kB pathway;Cytokine Signaling in Immune system;Immune System;TNFs bind their physiological receptors
(Consensus)
Recessive Scores
- pRec
- 0.169
Intolerance Scores
- loftool
- 0.0631
- rvis_EVS
- 0.82
- rvis_percentile_EVS
- 87.87
Haploinsufficiency Scores
- pHI
- 0.109
- hipred
- N
- hipred_score
- 0.257
- ghis
- 0.413
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.824
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Tnfsf9
- Phenotype
- immune system phenotype; hematopoietic system phenotype;
Gene ontology
- Biological process
- apoptotic process;immune response;signal transduction;cell-cell signaling;cell population proliferation;regulation of signaling receptor activity;tumor necrosis factor-mediated signaling pathway;positive regulation of activated T cell proliferation;positive regulation of cytotoxic T cell differentiation
- Cellular component
- extracellular space;plasma membrane;integral component of membrane
- Molecular function
- signaling receptor binding;cytokine activity;tumor necrosis factor receptor binding;tumor necrosis factor receptor superfamily binding